Accueil › Surpoids › Nevada › Las Vegas
Essais cliniques pour Surpoids à Las Vegas, NV
23 études pour Surpoids recherchent des participants dans et autour de Las Vegas (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Recrutement en coursPhase 2
- Vector Clinical Trials /ID# 282265, Las Vegas
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Recrutement en coursPhase 3
- Palm Research Center Inc., Las Vegas
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Recrutement en coursPhase 3
- M3 Wake Research - Las Vegas Cimarron, Las Vegas
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Recrutement en coursPhase 3
- Research Site, Las Vegas
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Recrutement en coursPhase 3
- Palm Research Center Tenaya, Las Vegas
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Recrutement en coursPhase 3
- Excel Clinical Research, Las Vegas
- Vector Clinical Trials, Las Vegas
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Recrutement en coursPhase 3
- AMR Clinical, Las Vegas
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Recrutement en coursPhase 2
- Las Vegas Medical Research, Las Vegas
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Recrutement en coursPhase 3
- AURORA-1 Clinical Site, Las Vegas
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Recrutement en coursPhase 3
- AURORA-2 Clinical Site, Las Vegas
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Recrutement en coursPhase 3Volontaires sains bienvenus
- ACCOMPLISH-2 Research Site, Las Vegas
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Recrutement en coursPhase 3
- Jubilee Clinical Research, Inc., Las Vegas
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Recrutement en coursPhase 2
- Las Vegas Medical Research, Las Vegas
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Recrutement en coursPhase 2
- Vector Clinical Trials, Las Vegas
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Recrutement en coursPhase 3
- Kailera Clinical Site, Las Vegas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Recrutement en coursPhase 3
- Palm Research Center Inc, Las Vegas
- Vector Clinical Trials, Las Vegas
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Recrutement en coursPhase 3
- Kailera Clinical Site, Las Vegas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Recrutement en coursPhase 3
- Palm Research Center Inc, Las Vegas
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Recrutement en coursPhase 3
- Excel Clinical Research, Las Vegas
Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.
Recrutement en coursVolontaires sains bienvenus
- University of Nevada, Las Vegas, Las Vegas
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Recrutement en coursPhase 3
- Research Site, Las Vegas
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Recrutement en coursPhase 3
- ACCOMPLISH-1 Research Site, Las Vegas
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
Recrutement en coursPhase 1
- Corxel Investigational site, Las Vegas
Essais pour Surpoids dans d'autres villes
- San Antonio, TX34 études
- Houston, TX33 études
- Chicago, IL28 études
- Orlando, FL27 études
- Miami, FL23 études
- Atlanta, GA20 études
- Dallas, TX20 études
- New York City, NY19 études
- Jacksonville, FL19 études
- Washington, DC19 études
- Austin, TX18 études
- Baltimore, MD17 études
Autres études à Las Vegas
- Obésité27 études
- Diabète de type 218 études
- Cancer du poumon non à petites cellules13 études
- Trouble dépressif majeur13 études
- Cancer du sein10 études
- Maladie d'Alzheimer8 études
- Cancer de la prostate8 études
- Leucémie aiguë myéloïde8 études
- Cancer (tous types)8 études
- Maladie hépatique stéatosique7 études
- Cancer de l'endomètre7 études
- Dépression7 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.